Search Results 1681-1690 of 17856 for Substance+dependence

  1. A Study to Test the Safety and Effectiveness of PF-00547659 for Patients who have Crohn's Disease - Mayo Clinic

    The purpose of this study is to assess the safety and effectiveness of PF-00547659 (experimental drug) for patients who have Crohn's disease that is ...

  2. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

    Use of any other experimental drug or therapy =< 28 days prior to registration on this study. NOTE: Patients on low dose prednisone (=< 10 mg) for treatment ...

  3. Encopresis - Diagnosis & treatment - Mayo Clinic

    To diagnose encopresis, a healthcare professional may: Perform a physical exam and discuss symptoms, bowel movements and eating habits to rule out physical ...

  4. Mayo Clinic News Network | Trusted Health News & Research

    Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival in preclinical glioblastoma models. Brittany Cordeiro.

  5. Seasonal affective disorder treatment: Choosing a light box - Mayo Clinic

    Light boxes aren't regulated by the Food and Drug Administration (FDA) ... Ambien: Is dependence a concern? Antidepressant withdrawal: Is there such a ...

  6. Publications - Scott H. Okuno, M.D. - Mayo Clinic

    RNA-dependent protein kinase is required for interferon-gamma-induced autophagy in MG63 osteosarcoma cells. Gene. 2021 Nov 15; 802:145865 Epub 2021 Aug 02

  7. Tebentafusp-tebn (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome - Mayo Clinic

    By condition, treatment or drug name ... Subject's caregiver is willing and able to be compliant with study procedures, visit schedule and study drug ...

  9. TX2® Low Profile TAA Endovascular Graft - Mayo Clinic

    By condition, treatment or drug name. Search tips. TX2® Low Profile TAA ... Less than 30 days beyond primary endpoint for other investigative drug or device study ...

  10. Publications - Sebastian S. Lopez Chiriboga, M.D. - Mayo Clinic

    2017. Feyissa AM, Lopez Chiriboga AS, Britton JW. Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4 ...